| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V6494 | AF64394 | 1637300-25-4 | AF64394 is an inverse agonist of GPR3 with pIC50 of 7.3. |
|
V3354 | APD 668 | 832714-46-2 | APD668 (also known as JNJ-28630368) is a novel and potent agonist of the pancreatic and GI-expressed orphan G-protein coupled receptor GPR119, with EC50 of 2.7 nM and 33 nM for hGPR119 and ratGPR119 respectively. |
|
V2826 | APD597 (JNJ38431055) | 897732-93-3 | APD597 (formerly known as JNJ-38431055) is a novel potent and selective GPR119 agonist/modulator, which has the potential for the treatment of type 2 diabetes. |
|
V29481 | AR 231453 | 733750-99-7 | AR231453 (AR-231453) is a potent, selective and orally bioavailable GPR119 agonist used as an antidiabetic agent. |
|
V5220 | CID-16020046 | 834903-43-4 | CID-16020046 (CI-16020046) is a novel, potent and selective GPR55 (LPI receptor) antagonist / inverse agonist which can block GPR55-mediated endothelial wound healing and reverse LPI-inhibited platelet aggregation. |
|
V30807 | DC260126 | 346692-04-4 | DC260126 is a potent GPR40 (FFAR1) antagonist. |
|
V3999 | DJ-V159 | 2253744-53-3 | DJ-V-159 is a novel and potent agonist for G protein-coupled receptor family C group 6 member A(GPRC6A) with the potential for treating type 2 diabetes mellitus (T2D). |
|
V21384 | FTBMT | 1358575-02-6 | FTBMT is a novel, potent, selective and orally bioavailable GPR52 agonist with antipsychotic and procognitive properties. |
|
V21931 | GTPL5846 | 83797-69-7 | 6-OAU (GTPL5846) is a GPR84 (G protein-coupled receptor 84) agonist with EC50 of 105 nM. |
|
V22911 | JMS-17-2 | 1380392-05-1 | JMS-17-2 is a novel, potent and selective antagonist of CX3CR1 with anticancer activity. |
|
V4029 | JNJ 63533054 | 1802326-66-4 | JNJ-63533054, a glycine benzamide analog, is a potent, selective and brain penetrant agonist of hGPR139 (human G-protein-coupled receptors) with an EC50 of 16 nM. |
|
V24432 | LP-471756 | 413605-11-5 | LP-471756 is a potent GPR139 antagonist (inhibitor) with IC50 of 640 nM. |
|
V25100 | MBX-2982 (SAR260093) | 1037792-44-1 | MBX-2982 (SAR-260093) is a novel, potent, selective and orally bioavailable G protein-coupled receptor 119 (GPR119) agonist with the potential for treating type 2 diabetes. |
|
V33730 | ML 145 | 1164500-72-4 | ML 145 is a selective, competitive human GPR35/CXCR8 antagonist (inhibitor) with IC50/EC50 of 20.1 nM. |
|
V18310 | ML184 (CID2440433) | 794572-10-4 | ML-184 (CID244033) is a selective GPR55 agonist with EC50 of 250 nM and is more than 100 times more selective for GPR55 than GPR35, CB1 and CB2. |
|
V2292 | ML-191 | 931695-79-3 | ML-191 is an antagonist of GPR55. |
|
V25659 | ML-193 | 713121-80-3 | ML-193 (ML193; CID-1261822; CID1261822) is a novel and potent GPR55 (G protein-coupled receptor 55) antagonist with IC50 of 221 nM. |
|
V24805 | ML401 | 1597489-14-9 | ML401 is a potent chemical probe that selectively antagonizes EBI2 (known also as GPR183) with IC50 of 1.03 nM. |
|
V32986 | NE 52-QQ57 | 1401728-56-0 | NE 52-QQ57 is a selective, orally bioactive GPR4 antagonist (inhibitor) with IC50 of 70 nM. |
|
V26464 | NIBR-189 | 1599432-08-2 | NIBR189 is an antagonist of EBI2 (Epstein-Barr virus-induced gene 2). |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
